Neurosoft Bioelectronics secures CHF 150k from Venture Kick.

Switzerland Investments 29 January 2021
Share on FacebookShare on Twitter

Neurosoft Bioelectronics, a Geneva, Switzerland-based biotech startup, announced securing CHF 150k ($170k).

The money was provided by Venture Kick.

Neurosoft Bioelectronics, founded in 2020 by Nicolas Vachicouras (CEO), Ludovic Serex, Florian Fallegger and St├ęphanie Lacour, are working for the next gen of implantable electrical interfaces.

Neural implants can be used to diagnose and treat neurological diseases by recording or electrically stimulating neural tissues. However, the long-term success of current neural interfaces is limited by the mechanical mismatch between stiff electronics and soft living tissues. This mismatch causes poor contact between the implant and the underlying tissue and leads to incorrect stimulation, inaccurate recordings, and scarring.